摘要
背景与目的:Smac是目前发现的惟一能直接同时抑制多个IAPs家族成员活性的凋亡相关蛋白,其N端的4个氨基酸残基AVPI(Ala-Val-Pro-Ile)是重要的促凋亡结构域,我们通过人工合成可穿透细胞的促凋亡融合多肽SmacN7,探讨其对膀胱癌化疗药物敏感性的促进作用。方法:噻唑蓝(MTT)检测SmacN7融合多肽对低剂量丝裂霉素C(MMC)诱导的膀胱癌T24细胞的相对存活率的影响:Annexin V/PI双标流式细胞术检测T24细胞的凋亡1;Western印迹检测SmacN7融合多肽与MMC联用后T24细胞内XIAP、Caspase-3的表达;同时检测Caspase-3活性及SmacN7融合多肽与MMC联用对T24细胞的杀伤作用。结果:SmacN7融合多肽能穿透细胞并与内源性XIAP结合,增加低剂量MMC诱导的T24细胞凋亡并呈时间和浓度依赖性:并能显著降低细胞内XIAP的表达水平,增强Caspase-3的表达及活性:在24 h和48 h,SmacN7+MMC组与单用MMCtg相比,T24细胞的存活率分别降低55%和72.7%。结论:人工合成可穿透细胞的促凋亡融合多肽SmacNT能促进化疗药物诱导的膀胱癌T24细胞凋亡,抑制细胞增殖,增强膀胱癌细胞对MMC的化疗药物敏感性。
Background and purpose: Smac/DIABLO was the only apoptosis-related protein that could inhibit IAPs directly and simultaneously. The four amino-residual AVPI(Ala-Val- Pro-Ile)in its N-terminal was the very important domain that could stimulate apoptosis. This study investigated the effect of synthetic Smac peptide (SmacN7) on chemotherapy sensitivity of bladder cancer cells. Methods: SmacN7 penetratin peptide was synthesized and delivered into T24 cells. MTT assay was adopted to evaluate the viability ofT24 cells induced by low-dosage of MMC. Flow cytometry was applied to analyze the proportion of apoptosis and Western blot was used to detect the expression of XIAP and caspase-3; The activity of caspase-3 was measured and the effect of SmacN7 combined with MMC on T24 cell lines was also determined. Results: SmacN7 penetratin peptide could successfully interact with endogenous XIAP and increase the proportions of apoptosis of T24 cell lines induced by low-dosage of MMC in a dose- and timedependent manner. An obvious down-regulation of XIAP expression and up-regulation of caspase-3 was identified by Western blot. The activity of caspase-3 in experimental group was significantly increased as compared with that in the control group; Combining the treatment with SmaeN7 penetratin peptide,the viability ofT24 cells decreased to 55% and 72.7% in 24 hrs and 48 hrs respectively. Couclusion: SmacN7 penetratin peptide could act as a cell-permeable IAP inhibitor, inhibit the proliferation, induce apoptosis and enhance the chemo-sensitivity of bladder cancer cells to MMC. When combined with chemotherapy, it may be a very promising strategy for bladder cancer therapy.
出处
《中国癌症杂志》
CAS
CSCD
2008年第11期806-810,共5页
China Oncology
基金
教育部高等学校博士学科点专项科研基金(20060487066)